Korean Market
EXCH
Kukje Pharma
★

Kukje Pharma Discloses Corporate Governance Report: Complies with 8 out of 15 Key Indicators, Establishes CEO Succession Rules and ERM System, Limited Short-term Impact on Shareholder Value

 
OWNR
Kukje Pharma
★

Vice President Kim Young-gwan Buys 2,000 Shares of Company Stock… Small but Shows Management Confidence

 
OWNR
Kukje Pharma
★

Largest Shareholder's Stake Slightly Increases to 37.93%... Insider Buying and Collateral Extension Maintains Management Stability

 
OWNR
Kukje Pharma
★

Kukje Pharma Non-Executive Choe Hae-seong Buys 2,521 Shares at 3,960 Won... Small Insider Buy Signals Management Confidence

 
EXCH
Kukje Pharma
★

Correction of Debt Guarantee Period for Affiliate Hyorim E&I (30 Billion Won, 30.71% of Equity)

 
PERI
Kukje Pharma
★

Kukje Pharma: Q1 2026 Sales +6%, Net Profit Up, Operating Profit Down; 30 Won Dividend